Matches in Wikidata for { <http://www.wikidata.org/entity/Q97649629> ?p ?o ?g. }
- Q97649629 description "2020 nî lūn-bûn" @default.
- Q97649629 description "2020年の論文" @default.
- Q97649629 description "2020年学术文章" @default.
- Q97649629 description "2020年学术文章" @default.
- Q97649629 description "2020年学术文章" @default.
- Q97649629 description "2020年学术文章" @default.
- Q97649629 description "2020年学术文章" @default.
- Q97649629 description "2020年学术文章" @default.
- Q97649629 description "2020年學術文章" @default.
- Q97649629 description "2020年學術文章" @default.
- Q97649629 description "2020年學術文章" @default.
- Q97649629 description "2020年學術文章" @default.
- Q97649629 description "2020年學術文章" @default.
- Q97649629 description "2020년 논문" @default.
- Q97649629 description "article científic" @default.
- Q97649629 description "article scientific" @default.
- Q97649629 description "article scientifique" @default.
- Q97649629 description "articol științific" @default.
- Q97649629 description "articolo scientifico" @default.
- Q97649629 description "artigo científico" @default.
- Q97649629 description "artigo científico" @default.
- Q97649629 description "artigo científico" @default.
- Q97649629 description "artikel ilmiah" @default.
- Q97649629 description "artikull shkencor" @default.
- Q97649629 description "artikulong pang-agham" @default.
- Q97649629 description "artykuł naukowy" @default.
- Q97649629 description "artículo científico publicado en 2020" @default.
- Q97649629 description "artículu científicu" @default.
- Q97649629 description "bilimsel makale" @default.
- Q97649629 description "bài báo khoa học" @default.
- Q97649629 description "naučni članak" @default.
- Q97649629 description "scienca artikolo" @default.
- Q97649629 description "scientific article published on 22 July 2020" @default.
- Q97649629 description "scientific article published on 22 July 2020" @default.
- Q97649629 description "scientific article published on 22 July 2020" @default.
- Q97649629 description "teaduslik artikkel" @default.
- Q97649629 description "tieteellinen artikkeli" @default.
- Q97649629 description "tudományos cikk" @default.
- Q97649629 description "vedecký článok" @default.
- Q97649629 description "vetenskaplig artikel" @default.
- Q97649629 description "videnskabelig artikel udgivet 22. juli 2020" @default.
- Q97649629 description "vitenskapelig artikkel" @default.
- Q97649629 description "vitskapeleg artikkel" @default.
- Q97649629 description "vědecký článek" @default.
- Q97649629 description "wetenschappelijk artikel" @default.
- Q97649629 description "wissenschaftlicher Artikel" @default.
- Q97649629 description "επιστημονικό άρθρο" @default.
- Q97649629 description "мақолаи илмӣ" @default.
- Q97649629 description "наукова стаття, опублікована в липні 2020" @default.
- Q97649629 description "научна статия" @default.
- Q97649629 description "научная статья" @default.
- Q97649629 description "научни чланак" @default.
- Q97649629 description "научни чланак" @default.
- Q97649629 description "מאמר מדעי" @default.
- Q97649629 description "مقالة علمية نشرت في 22 يوليو 2020" @default.
- Q97649629 description "২২ জুলাই ২০২০-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q97649629 description "บทความทางวิทยาศาสตร์" @default.
- Q97649629 description "სამეცნიერო სტატია" @default.
- Q97649629 name "Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients" @default.
- Q97649629 name "Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients" @default.
- Q97649629 type Item @default.
- Q97649629 label "Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients" @default.
- Q97649629 label "Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients" @default.
- Q97649629 prefLabel "Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients" @default.
- Q97649629 prefLabel "Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients" @default.
- Q97649629 P1433 Q97649629-C87EEA02-E126-4D4E-B574-D707930E42C7 @default.
- Q97649629 P1476 Q97649629-20F4E2CE-5E5D-4E55-B4FB-2104CD396816 @default.
- Q97649629 P2093 Q97649629-4F90DAE7-A662-42E6-B077-75E7F307AA4C @default.
- Q97649629 P2093 Q97649629-63A0EA1F-929F-4792-80C9-82B0873F0E0B @default.
- Q97649629 P2093 Q97649629-6A5169B4-4D29-43F9-9D68-715DA8A98D2D @default.
- Q97649629 P2093 Q97649629-F09C6086-7FED-46C7-902F-50BA2DEBDC3C @default.
- Q97649629 P31 Q97649629-6F06CB62-5C3E-4CBC-9A14-A393EC7377AC @default.
- Q97649629 P356 Q97649629-D37EE0E9-FC6B-48AF-9B5A-F93480E4101C @default.
- Q97649629 P50 Q97649629-066E3706-6964-42D5-ABFE-712E6DC4F510 @default.
- Q97649629 P50 Q97649629-16D1D5AC-5CB1-4FF0-AD5F-1978F1885195 @default.
- Q97649629 P50 Q97649629-21004523-E925-45A5-9F56-E4AE6EF14F04 @default.
- Q97649629 P50 Q97649629-27FDC065-22A1-4032-96AD-B77BCF797F06 @default.
- Q97649629 P50 Q97649629-56F9A71D-E163-4AC4-93CC-4B6B702A8422 @default.
- Q97649629 P50 Q97649629-A6522A23-C5A7-4840-9F8D-9DFA1EC36B77 @default.
- Q97649629 P50 Q97649629-A90BE990-BAF5-40C9-80A4-17C3EEED1920 @default.
- Q97649629 P50 Q97649629-C3B2CBAB-9B26-4CA7-8D48-BD7898834415 @default.
- Q97649629 P50 Q97649629-D4FD03F7-6D9C-4322-AD12-39ECF24C9C7D @default.
- Q97649629 P50 Q97649629-DD06A940-E65E-4E48-B11E-9F23EAEE8214 @default.
- Q97649629 P50 Q97649629-E8788289-7E91-44D6-89D7-8FBFE815052C @default.
- Q97649629 P577 Q97649629-7394706B-93ED-471A-9B77-52A639F7B43F @default.
- Q97649629 P698 Q97649629-96760B50-49FE-46F5-8B72-641AA492A503 @default.
- Q97649629 P356 AJH.25943 @default.
- Q97649629 P698 32697348 @default.
- Q97649629 P1433 Q4744246 @default.
- Q97649629 P1476 "Phase 1 Study of combinatorial sorafenib, G-CSF, and plerixafor treatment in relapsed/refractory, FLT3-ITD-mutated acute myelogenous leukemia patients" @default.
- Q97649629 P2093 "Farhad Ravandi" @default.
- Q97649629 P2093 "Hsiang-Chun Chen" @default.
- Q97649629 P2093 "Mary A Kelly" @default.
- Q97649629 P2093 "Ru-Yiu Wang" @default.
- Q97649629 P31 Q13442814 @default.
- Q97649629 P356 "10.1002/AJH.25943" @default.
- Q97649629 P50 Q114427914 @default.
- Q97649629 P50 Q60320900 @default.
- Q97649629 P50 Q60394812 @default.
- Q97649629 P50 Q66385504 @default.